tradingkey.logo
怜玢
マヌケット
ニュヌス
分析
ツヌル
株匏スクリヌナヌ


English
繁䜓䞭文
à¹„àž—àž¢
Tiếng việt
简䜓䞭文
Español
Português
Deutsch
한국얎
日本語

tradingkey.logo
怜玢



Ascendis Pharma A/S

ASND
りォッチリストに远加
238.670USD
+0.010+0.00%
終倀 05/11, 16:00ET15分遅れの株䟡
14.82B時䟡総額
34.39盎近12ヶ月PER


Ascendis Pharma A/S

238.670
+0.010+0.00%
抂芁金融ディスカッション分析䌁業名

抂芁

金融

ディスカッション

分析

䌁業名

詳现情報 Ascendis Pharma A/S 䌁業名

Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).

Ascendis Pharma A/Sの䌁業情報


䌁業コヌドASND
䌚瀟名Ascendis Pharma A/S
䞊堎日Jan 28, 2015
最高経営責任者「CEO」Moller Mikkelsen (Jan)
埓業員数- -
蚌刞皮類Depository Receipt
決算期末Jan 28
本瀟所圚地Tuborg Boulevard 12
郜垂HELLERUP
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Denmark
郵䟿番号2900
電話番号4570222244
りェブサむトhttps://ascendispharma.dk/
䌁業コヌドASND
䞊堎日Jan 28, 2015
最高経営責任者「CEO」Moller Mikkelsen (Jan)

Ascendis Pharma A/Sの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+66.49%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.66K
+40.20%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
1.10K
+66.82%
Mr. Jan Moller Mikkelsen
Mr. Jan Moller Mikkelsen
President, Chief Executive Officer, Executive Director, Member of the Executive Board
President, Chief Executive Officer, Executive Director, Member of the Executive Board
--
--
Ms. Lotte Soenderbjerg
Ms. Lotte Soenderbjerg
Executive Vice President, Chief Administrative Officer, Member of the Executive Board
Executive Vice President, Chief Administrative Officer, Member of the Executive Board
--
--
Dr. Kennett Sprogoee, Ph.D.
Dr. Kennett Sprogoee, Ph.D.
Executive Vice President, Head of Innovation and Research
Executive Vice President, Head of Innovation and Research
--
--
Mr. Scott T. Smith
Mr. Scott T. Smith
Chief Financial Officer, Executive Vice President, Member of the Executive Board
Chief Financial Officer, Executive Vice President, Member of the Executive Board
--
--
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
--
-100.00%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+66.49%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.66K
+40.20%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
1.10K
+66.82%
Mr. Jan Moller Mikkelsen
Mr. Jan Moller Mikkelsen
President, Chief Executive Officer, Executive Director, Member of the Executive Board
President, Chief Executive Officer, Executive Director, Member of the Executive Board
--
--

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別USD
䌚瀟名
収益
比率
Commercial sale of products
683.57M
94.92%
Rendering of services
18.01M
2.50%
Milestones
12.92M
1.79%
License
5.63M
0.78%
地域別USD
䌚瀟名
収益
比率
North America
546.39M
75.87%
Europe
108.05M
15.00%
Rest of world
52.80M
7.33%
Denmark
12.90M
1.79%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Commercial sale of products
683.57M
94.92%
Rendering of services
18.01M
2.50%
Milestones
12.92M
1.79%
License
5.63M
0.78%

株䞻

曎新時刻: Mon, May 11
曎新時刻: Mon, May 11
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
RA Capital Management, LP
16.55%
Westfield Capital Management Company, L.P.
8.35%
Avoro Capital Advisors LLC
8.23%
Janus Henderson Investors
6.54%
Fidelity Management & Research Company LLC
6.12%
他の
54.21%
株䞻統蚈
株䞻統蚈
比率
RA Capital Management, LP
16.55%
Westfield Capital Management Company, L.P.
8.35%
Avoro Capital Advisors LLC
8.23%
Janus Henderson Investors
6.54%
Fidelity Management & Research Company LLC
6.12%
他の
54.21%
皮類
株䞻統蚈
比率
Investment Advisor/Hedge Fund
42.09%
Investment Advisor
36.61%
Venture Capital
16.77%
Hedge Fund
6.19%
Research Firm
3.18%
Private Equity
2.23%
Individual Investor
0.82%
Pension Fund
0.43%
Sovereign Wealth Fund
0.38%

機関投資家保有株


曎新時刻: Sun, Apr 5
曎新時刻: Sun, Apr 5
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
582
69.20M
111.42%
-1.68M
2025Q4
523
68.62M
116.45%
+3.30K
2025Q3
540
68.73M
112.39%
+4.25M
2025Q2
515
64.43M
118.51%
-2.60M
2025Q1
495
67.05M
117.13%
-3.67M
2024Q4
471
65.26M
121.58%
+1.14M
2024Q3
461
64.02M
116.74%
+1.57M
2024Q2
446
62.31M
123.50%
-4.72K
2024Q1
440
62.32M
122.74%
-9.15M
2023Q4
415
61.74M
123.84%
-59.49K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
RA Capital Management, LP
10.28M
16.59%
--
--
Dec 31, 2025
Westfield Capital Management Company, L.P.
5.19M
8.37%
-74.21K
-1.41%
Dec 31, 2025
Avoro Capital Advisors LLC
5.11M
8.25%
+1.11K
+0.02%
Dec 31, 2025
Janus Henderson Investors
4.06M
6.55%
-261.42K
-6.05%
Dec 31, 2025
Fidelity Management & Research Company LLC
3.80M
6.13%
-317.86K
-7.72%
Dec 31, 2025
Artisan Partners Limited Partnership
3.23M
5.2%
-495.00K
-13.30%
Dec 31, 2025
Capital International Investors
3.06M
4.94%
+3.33K
+0.11%
Dec 31, 2025
MFS Investment Management
1.88M
3.04%
+3.94K
+0.21%
Dec 31, 2025
Wellington Management Company, LLP
1.76M
2.84%
-36.21K
-2.01%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
1.67M
2.69%
-998.99K
-37.46%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Harbor Health Care ETF
17.71%
American Century Focused Dynamic Growth ETF
2.8%
AdvisorShares Dorsey Wright ADR ETF
2.62%
Virtus LifeSci Biotech Products ETF
1.89%
Tema Heart & Health ETF
1.45%
ProShares Ultra Nasdaq Biotechnology
1.2%
Invesco Nasdaq Biotechnology ETF
1.19%
First Trust Innovation Leaders ETF
1.18%
Putnam Sustainable Future ETF
1.11%
Main Thematic Innovation ETF
1.07%
詳现を芋る
Harbor Health Care ETF
比率17.71%
American Century Focused Dynamic Growth ETF
比率2.8%
AdvisorShares Dorsey Wright ADR ETF
比率2.62%
Virtus LifeSci Biotech Products ETF
比率1.89%
Tema Heart & Health ETF
比率1.45%
ProShares Ultra Nasdaq Biotechnology
比率1.2%
Invesco Nasdaq Biotechnology ETF
比率1.19%
First Trust Innovation Leaders ETF
比率1.18%
Putnam Sustainable Future ETF
比率1.11%
Main Thematic Innovation ETF
比率1.07%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™